Clinical trial
Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human…
NCT00000955 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000955 |
|---|---|
| Title | Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection |
| Official title | Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Warner Lambert - Parke Davis Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | Tuberculin Purified Protein Derivative |
| Enrollment | 864 |
| Primary completion | Dec 1, 1992 |
| Completion | Dec 1, 1992 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 1, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: